Diana A Chirinos1, Kyle W Murdock2, Angie S LeRoy3, Christopher Fagundes4. 1. Department of Psychology, Rice University, Houston, TX, United States. Electronic address: dcm5@rice.edu. 2. Department of Psychology, Rice University, Houston, TX, United States. 3. Department of Psychology, Rice University, Houston, TX, United States; Department of Psychology, University of Houston, Houston, TX, United States. 4. Department of Psychology, Rice University, Houston, TX, United States; Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, TX, United States; Department of Psychiatry, Baylor College of Medicine, Houston, TX, United States.
Abstract
BACKGROUND: This study aimed to (1) provide a comprehensive characterization of depressive symptoms profiles, and (2) examine the cross-sectional association between depressive symptom profiles and cardio-metabolic outcomes, including metabolic syndrome and obesity, while controlling for sociodemographic variables, health behaviors and inflammation. METHODS: Our sample was comprised of 1085 participants (55.80% female) enrolled in the MIDUS-II biomarker study. Latent profile analysis (LPA) was used to derive depressive symptom profiles using subscales of the Mood and Anxiety Symptom Questionnaire (MASQ) and the Center for Epidemiologic Studies Depression Scale (CES-D) subscales as well as Pittsburgh Sleep Quality Index (PSQI) global score. Metabolic syndrome was defined according to the Interim Joint Statement definition. CRP was used as a marker of inflammation. RESULTS: Four depressive symptom profiles were identified. The "No Symptoms" subgroup (60.65% of the sample) had the lowest overall scores across subscales. The "Mild Symptoms" subgroup (26.73%) was characterized by lower scores across indicators, with subscales measuring somatic symptoms being the highest within group. The "Moderate Symptoms" subgroup (10.32%) had higher scores across subscales (1 SD above the mean), with subscales measuring negative affect/loss of interest being the highest within group. Finally, the "Acute symptoms" subgroup (2.30%) was characterized by the highest overall scores (1.5-3 SD above the mean) on all indicators. After controlling for sociodemographic characteristics and health behaviors, the "Moderate Symptoms" subgroup was significantly associated with metabolic syndrome (OR=1.595, p=0.035) and obesity (OR=1.555, p=0.046). Further, there was a trend between the "Mild Symptoms" subgroup and the presence of obesity (OR=1.345, p=0.050). Inflammation attenuated these associations. CONCLUSIONS: Four depressive symptom profiles were identified among healthy mid-life individuals in the US. These profiles are differentially associated with cardio-metabolic outcomes. Future work should examine whether distinct symptom profiles may reflect differential pathways to increased risk, and whether tailored management of symptoms is needed.
BACKGROUND: This study aimed to (1) provide a comprehensive characterization of depressive symptoms profiles, and (2) examine the cross-sectional association between depressive symptom profiles and cardio-metabolic outcomes, including metabolic syndrome and obesity, while controlling for sociodemographic variables, health behaviors and inflammation. METHODS: Our sample was comprised of 1085 participants (55.80% female) enrolled in the MIDUS-II biomarker study. Latent profile analysis (LPA) was used to derive depressive symptom profiles using subscales of the Mood and Anxiety Symptom Questionnaire (MASQ) and the Center for Epidemiologic Studies Depression Scale (CES-D) subscales as well as Pittsburgh Sleep Quality Index (PSQI) global score. Metabolic syndrome was defined according to the Interim Joint Statement definition. CRP was used as a marker of inflammation. RESULTS: Four depressive symptom profiles were identified. The "No Symptoms" subgroup (60.65% of the sample) had the lowest overall scores across subscales. The "Mild Symptoms" subgroup (26.73%) was characterized by lower scores across indicators, with subscales measuring somatic symptoms being the highest within group. The "Moderate Symptoms" subgroup (10.32%) had higher scores across subscales (1 SD above the mean), with subscales measuring negative affect/loss of interest being the highest within group. Finally, the "Acute symptoms" subgroup (2.30%) was characterized by the highest overall scores (1.5-3 SD above the mean) on all indicators. After controlling for sociodemographic characteristics and health behaviors, the "Moderate Symptoms" subgroup was significantly associated with metabolic syndrome (OR=1.595, p=0.035) and obesity (OR=1.555, p=0.046). Further, there was a trend between the "Mild Symptoms" subgroup and the presence of obesity (OR=1.345, p=0.050). Inflammation attenuated these associations. CONCLUSIONS: Four depressive symptom profiles were identified among healthy mid-life individuals in the US. These profiles are differentially associated with cardio-metabolic outcomes. Future work should examine whether distinct symptom profiles may reflect differential pathways to increased risk, and whether tailored management of symptoms is needed.
Authors: Petra W Hoen; Henk Jan Conradi; Johan Denollet; Elisabeth J Martens; Peter de Jonge Journal: Psychother Psychosom Date: 2010-08-02 Impact factor: 17.659
Authors: Femke Lamers; Peter de Jonge; Willem A Nolen; Johannes H Smit; Frans G Zitman; Aartjan T F Beekman; Brenda W J H Penninx Journal: J Clin Psychiatry Date: 2010-07-13 Impact factor: 4.384
Authors: Nicole Vogelzangs; Aartjan T F Beekman; Ingrid G Boelhouwer; Stefania Bandinelli; Yuri Milaneschi; Luigi Ferrucci; Brenda W J H Penninx Journal: J Clin Psychiatry Date: 2011-04-05 Impact factor: 4.384
Authors: Beverly H Brummett; Michael A Babyak; Ilene C Siegler; Daniel B Mark; Redford B Williams; John C Barefoot Journal: Am J Cardiol Date: 2003-09-01 Impact factor: 2.778
Authors: Veronica Y Womack; Peter John De Chavez; Sandra S Albrecht; Nefertiti Durant; Eric B Loucks; Eli Puterman; Nicole Redmond; Juned Siddique; David R Williams; Mercedes R Carnethon Journal: Psychosom Med Date: 2016-09 Impact factor: 3.864
Authors: Emily A Vargas; Diana A Chirinos; Mandy Wong; Mercedes R Carnethon; Allison J Carroll; Catarina I Kiefe; April P Carson; Kiarri N Kershaw Journal: J Behav Med Date: 2021-10-20
Authors: Marie T Banich; Louisa L Smith; Harry R Smolker; Benjamin L Hankin; Rebecca L Silton; Wendy Heller; Hannah R Snyder Journal: Int J Psychophysiol Date: 2020-02-04 Impact factor: 2.903
Authors: Loni Berkowitz; Marcela P Henríquez; Cristian Salazar; Eric Rojas; Guadalupe Echeverría; Gayle D Love; Attilio Rigotti; Christopher L Coe; Carol D Ryff Journal: Sci Rep Date: 2021-06-23 Impact factor: 4.379